JOP20200323A1 - طرق لتصنيع تركيبات الأحماض الأمينية - Google Patents

طرق لتصنيع تركيبات الأحماض الأمينية

Info

Publication number
JOP20200323A1
JOP20200323A1 JOP/2020/0323A JOP20200323A JOP20200323A1 JO P20200323 A1 JOP20200323 A1 JO P20200323A1 JO P20200323 A JOP20200323 A JO P20200323A JO P20200323 A1 JOP20200323 A1 JO P20200323A1
Authority
JO
Jordan
Prior art keywords
methods
amino acid
acid compositions
manufacturing amino
manufacturing
Prior art date
Application number
JOP/2020/0323A
Other languages
English (en)
Inventor
Andrew M Wood
Thomas Hanlon
Ralph Yamamoto
Daniel Rothenberg
Denise K Kwok
Original Assignee
Axcella Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axcella Health Inc filed Critical Axcella Health Inc
Publication of JOP20200323A1 publication Critical patent/JOP20200323A1/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

يوفر الكشف الحالي طرق لتصنيع مستحضرات ممزوجة واسعة النطاق تشتمل على واحد أو أكثر من الأحماض الأمينية حيث يكون للمستحضرات خواص معينة.
JOP/2020/0323A 2018-06-20 2019-06-19 طرق لتصنيع تركيبات الأحماض الأمينية JOP20200323A1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862687725P 2018-06-20 2018-06-20

Publications (1)

Publication Number Publication Date
JOP20200323A1 true JOP20200323A1 (ar) 2020-12-14

Family

ID=67226342

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2020/0323A JOP20200323A1 (ar) 2018-06-20 2019-06-19 طرق لتصنيع تركيبات الأحماض الأمينية

Country Status (17)

Country Link
US (1) US11679089B2 (ar)
EP (1) EP3810168A1 (ar)
JP (1) JP2021529735A (ar)
KR (1) KR20210023846A (ar)
CN (1) CN112823018A (ar)
AR (1) AR115581A1 (ar)
AU (1) AU2019288371A1 (ar)
BR (1) BR112020025831A2 (ar)
CA (1) CA3099762A1 (ar)
CL (1) CL2020003277A1 (ar)
IL (1) IL279328A (ar)
JO (1) JOP20200323A1 (ar)
MA (1) MA52957A (ar)
MX (1) MX2020013732A (ar)
SG (1) SG11202011611XA (ar)
TW (1) TW202015668A (ar)
WO (1) WO2019246201A1 (ar)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
US11617731B2 (en) 2017-04-28 2023-04-04 Axcella Health, Inc. Amino acid compositions and their use for the treatment of traumatic brain injury
SG11202001142VA (en) 2017-08-14 2020-03-30 Axcella Health Inc Amino acid compositions for the treatment of liver disease
AR115581A1 (es) 2018-06-20 2021-02-03 Axcella Health Inc Métodos de preparación de composiciones de aminoácidos
US10596136B2 (en) 2018-06-20 2020-03-24 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
CU20200106A7 (es) 2018-06-20 2021-08-06 Axcella Health Inc Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias
JP2024529966A (ja) 2021-07-26 2024-08-14 アクセラ（アサインメント フォ ザ ベネフィット オブ クレディターズ），エルエルシー Ｃｏｖｉｄ－１９の急性期後後遺症の治療に使用するためのアミノ酸組成物及び方法
NL2038264B1 (en) * 2024-07-18 2025-03-06 West China Hospital Sichuan Univ Compound nutritional preparation for reducing fat and increasing muscle and preparation method thereof

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
CA2143420C (en) 1992-12-23 1999-01-19 Phyllis J. B. Acosta Medical foods for the nutritional support of infant/toddler metabolic diseases
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
EP0891719A1 (en) 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
US20010041187A1 (en) 1998-10-20 2001-11-15 Carl W Hastings Performance-enhancing dietary supplement
US20040047904A1 (en) * 2001-11-13 2004-03-11 Motohiro Ohta Amino acid-containing tablets quickly disintegrating in the oral cavity and process for producing the same
DE602004001727T2 (de) 2003-04-07 2007-08-02 Novetide Ltd. Verfahren zur herstellung cyclischer peptide
US20040213838A1 (en) 2003-04-24 2004-10-28 Mazer Terrence B. Medical food tablets containing free amino acids
EP1699458A4 (en) 2003-12-30 2012-04-25 Reddys Lab Ltd Dr PHARMACEUTICAL COMPOSITION
US20060073254A1 (en) 2004-10-04 2006-04-06 Steve Catani No-carb tabletop sweeteners substitute
JPWO2006062238A1 (ja) 2004-12-07 2008-06-12 味の素株式会社 アミノ酸の微粉末及びその懸濁液
US20070286909A1 (en) * 2006-06-07 2007-12-13 Daniel S. Smith Amino acid compositions
WO2011043647A1 (en) * 2009-10-09 2011-04-14 N.V. Nutricia Amino acid composition with improved dispersibility
JP2012136492A (ja) 2010-12-25 2012-07-19 Shiga Prefecture Seiyaku Kk 服用感を改善された漢方内服液剤
WO2015002527A1 (en) * 2013-07-05 2015-01-08 N.V. Nutricia Amino acid composition for use in the treatment of a pdd
EP3738590A1 (en) 2013-07-31 2020-11-18 Leeds Beckett University Dietary supplement comprising amino acids for the treatment of sarcopenia
EP3048904A2 (en) 2013-09-25 2016-08-03 Pronutria Biosciences, Inc. Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof
US20180125926A1 (en) 2013-09-25 2018-05-10 Axcella Health Inc. Compositions and Formulations and Methods of Production and Use Thereof
FR3032883B1 (fr) 2015-02-24 2017-03-17 International Nutrition Res Company Composition pour la prevention et le traitement de la steatose et de la steatohepatite metaboliques
JO3543B1 (ar) * 2015-09-28 2020-07-05 Applied Pharma Res تراكيب حمض أميني إصدار معدل تعطى عن طريق الفم
KR20190005823A (ko) * 2016-02-04 2019-01-16 잡 리써치 앤드 디벨롭먼트, 엘엘씨 제어된-방출 및 혼층 사이클로덱스트린 내포 복합체 비히클
PL238958B1 (pl) * 2016-06-29 2021-10-25 Olimp Laboratories Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja aminokwasowa do stosowania przed wysiłkiem fizycznym
US20180015122A1 (en) * 2016-07-14 2018-01-18 Companion Supplements, LLC Pharmaceutical composition effective in preventing adverse effects associated with the use of glucocorticoids
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
JOP20190147A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض واضطرابات العضلات
JP2018154598A (ja) 2017-03-21 2018-10-04 株式会社明治 アミノ酸含有顆粒およびその製造方法
US11617731B2 (en) 2017-04-28 2023-04-04 Axcella Health, Inc. Amino acid compositions and their use for the treatment of traumatic brain injury
SG11202001142VA (en) 2017-08-14 2020-03-30 Axcella Health Inc Amino acid compositions for the treatment of liver disease
JP7370960B2 (ja) 2017-08-14 2023-10-30 アクセラ・ヘルス・インコーポレイテッド 神経細胞損傷の治療のためのアミノ酸組成物
WO2019246310A1 (en) 2018-06-20 2019-12-26 Axcella Health Inc. Compositions and methods for the reduction or treatment of inflammation
CU20200106A7 (es) 2018-06-20 2021-08-06 Axcella Health Inc Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias
US10596136B2 (en) 2018-06-20 2020-03-24 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
JP2021528420A (ja) 2018-06-20 2021-10-21 アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． 苦味のあるアミノ酸を含む治療及び健康のための組成物
WO2019246298A1 (en) 2018-06-20 2019-12-26 Axcella Health Inc. Compositions and methods for the reduction or treatment of fibrosis
WO2019246221A1 (en) 2018-06-20 2019-12-26 Axcella Health Inc. Compositions and methods for the treatment of liver diseases and disorders
JP2021527671A (ja) 2018-06-20 2021-10-14 アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． インスリン抵抗性及び代謝疾患の軽減又は治療のための組成物及び方法
AR115581A1 (es) 2018-06-20 2021-02-03 Axcella Health Inc Métodos de preparación de composiciones de aminoácidos

Also Published As

Publication number Publication date
US20190388374A1 (en) 2019-12-26
TW202015668A (zh) 2020-05-01
AR115581A1 (es) 2021-02-03
JP2021529735A (ja) 2021-11-04
CA3099762A1 (en) 2019-12-26
MA52957A (fr) 2021-04-28
IL279328A (en) 2021-01-31
MX2020013732A (es) 2021-02-26
KR20210023846A (ko) 2021-03-04
EP3810168A1 (en) 2021-04-28
SG11202011611XA (en) 2021-01-28
CN112823018A (zh) 2021-05-18
US11679089B2 (en) 2023-06-20
WO2019246201A1 (en) 2019-12-26
BR112020025831A2 (pt) 2021-03-23
CL2020003277A1 (es) 2021-07-09
AU2019288371A1 (en) 2020-12-03

Similar Documents

Publication Publication Date Title
MX2022006759A (es) Composiciones de proteina anti-vegf y metodos para producir la misma.
CY1124806T1 (el) Αντισωματα enanti-cd40 και χρησεις αυτων
EA202090090A1 (ru) Включение неприродных нуклеотидов и способы с ними
MX2020013732A (es) Metodos de fabricacion de composiciones de aminoacidos.
EA201992019A1 (ru) Съедобные и биоразлагаемые столовые приборы
EA201890749A1 (ru) ИНГИБИТОРЫ АЦЕТИЛ-КоА-КАРБОКСИЛАЗЫ (ACC) И ИХ ПРИМЕНЕНИЕ
MX383537B (es) Mutantes de proteína f de rsv.
TN2018000276A1 (en) Inhibitors of receptor-interacting protein kinase 1.
MX381487B (es) Ciertos inhibidores de la proteina quinasa.
EA201691794A1 (ru) Конденсированные [1,4]диазепиновые соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa)
MX2018010983A (es) Derivado de 3-desoxi y composiciones farmaceuticas del mismo.
MX385972B (es) Partículas y composiciones de nicotina.
EA201890815A1 (ru) Аминокислотные композиции с модифицированным высвобождением для перорального введения
EA202092692A1 (ru) Аналоги рапамицина и их применения
EA201692548A1 (ru) Минеральные аминокислотные комплексы активных веществ
MX2022007275A (es) Composiciones de acidos biliares y compuestos de fenilbutirato.
MX2020008125A (es) Composiciones que comprenden berberina.
MX2018010801A (es) Derivados de acido a-truxilico y composiciones farmaceuticas de los mismos.
MY192958A (en) Mixed decyl mercaptans compositions and methods of making same
CL2021001689A1 (es) Ácido r-piridiloxicarboxílico y sal, derivado del éster, método de preparación, composición herbicida y aplicación del mismo.
MX2022003879A (es) Proceso para elaborar acidos alcansulfonicos.
EA201890799A1 (ru) Производные азетидина для визуализации тау-белка
MX2021015879A (es) Peptidos restringidos.
JOP20200066B1 (ar) طريقة لتحضير أحماض ألفا هالو ألكانويك لا تماثلية
DK3989999T3 (da) Ny sammensætning indeholdende forgrenede aminosyrer